share_log

Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(47.7%),Peter Kolchinsky(47.7%), etc.

Eliem Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(47.7%),Peter Kolchinsky(47.7%)等

SEC announcement ·  2023/11/17 16:30
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息